RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer
F. Schipani, M. Manerba, R. Marotta, A. Gennari, F. Rinaldi, A. Armirotti, M. Roberti, G. Di Stefano, W. Rocchia, N. Tirelli, S. Girotto, A. Cavalli
This study investigates BRC4's role in inhibiting RAD51's nuclear recruitment and its effect on HR in pancreatic cancer cells, showing enhanced cisplatin cytotoxicity.
bioRxiv · Feb 3, 2021 · PreprintBiophysics